Here's Why Benitec Biopharma Stock Soared 79.7% Higher This Morning
The company announced preclinical data supporting its gene replacement therapy in a rare muscle disease.
BENITEC BIOPHARMA
The company announced preclinical data supporting its gene replacement therapy in a rare muscle disease.